Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

February 6, 2024


Screening and surveillance for hereditary colorectal cancer
Hee Man Kim, Tae Il Kim
Intest Res. 2024;22(2):119-130.

Review

February 1, 2024


Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration
Chang Kyo Oh, Young-Seok Cho
Intest Res. 2024;22(2):131-151.

Original Article

January 5, 2024


Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease
Anuj Bohra, Declan J Connoley, Danny Con, et al.
Intest Res. 2024;22(2):152-161.

Original Article

January 22, 2024


Sarcopenia is common in ulcerative colitis and correlates with disease activity
Pardhu B Neelam, Rimesh Pal, Pankaj Gupta, et al.
Intest Res. 2024;22(2):162-171.

Original Article

April 25, 2024


Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies
Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, et al.
Intest Res. 2024;22(2):172-185.

Original Article

April 25, 2024


A survey of current practices in post-polypectomy surveillance in Korea
Jeongseok Kim, Tae-Geun Gweon, Min Seob Kwak, et al.
Intest Res. 2024;22(2):186-207.

Original Article

February 6, 2024


Unraveling molecular similarities between colorectal polyps and colorectal cancer: a systems biology approach
Mehran Radak, Hossein Fallahi
Intest Res. 2024;22(2):199-207.

Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, et al.
[Epub ahead of print]

Original Article

Epub May 22, 2024

What to do when traditional rescue therapies fail in acute severe ulcerative colitis
Christopher F. D. Li Wai Suen, Matthew C. Choy, Peter De Cruz
[Epub ahead of print]

Review

Epub May 16, 2024

Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, et al.
[Epub ahead of print]

Original Article

Epub May 16, 2024

Halitosis: an underestimated but important extraintestinal manifestation in inflammatory bowel disease
Xiao Xian Qian
[Epub ahead of print]

Letter to the Editor

Epub May 7, 2024

Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy
Ryoya Sakakibara, Shinya Sugimoto, Kaoru Takabayashi, et al.
[Epub ahead of print]

Original Article

Epub May 7, 2024

Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study
Danny Con, Peter De Cruz
[Epub ahead of print]

Original Article

Epub May 7, 2024

Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn’s disease small bowel lesion in capsule endoscopy
Teppei Omori, Miki Koroku, Shun Murasugi, et al.
[Epub ahead of print]

Original Article

Epub May 7, 2024

Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study
Xinyu Liu, Qingfan Yang, Na Diao, et al.
[Epub ahead of print]

Original Article

Epub May 7, 2024

Cardiovascular disease: extraintestinal manifestation of inflammatory bowel disease
Samridhi Lakhanpal, Kanishk Aggarwal, Harmanjit Kaur, et al.
[Epub ahead of print]

Review

Epub May 7, 2024

Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, et al.
[Epub ahead of print]

Original Article

Epub March 26, 2024

Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective
Amal Arifi Hidayat, Langgeng Agung Waskito, Titong Sugihartono, et al.
[Epub ahead of print]

Review

Epub March 26, 2024

Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, et al.
[Epub ahead of print]

Original Article

Epub March 26, 2024

The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T. Rubin
[Epub ahead of print]

Review

Epub March 13, 2024

Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, et al.
[Epub ahead of print]

Original Article

Epub February 21, 2024

Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing
Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, et al.
[Epub ahead of print]

Original Article

Epub February 6, 2024

Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study
Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, et al.
[Epub ahead of print]

Original Article

Epub February 6, 2024

Helminths in alternative therapeutics of inflammatory bowel disease
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, et al.
[Epub ahead of print]

Review

Epub January 12, 2024

Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, et al.
[Epub ahead of print]

Original Article

Epub November 9, 2023

  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next